Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BDL Regimen for MDR-TB/RR-TB in China
NCT06476210Phase 4Recruiting
- Sponsor
- Beijing Chest Hospital
- Start
- Jun 2024
- Primary completion
- Jun 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of bedaquiline, delamanid, linezolid in pulmonary tuberculosis (TB), sponsored by Beijing Chest Hospital. Started Jun 2024; status: recruiting.
02
Drugs
bedaquilinedelamanidlinezolid
03
Conditions
pulmonary tuberculosis (TB)
Beyond the preview
Go deeper on NCT06476210.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06476210.